Nefazodone: Difference between revisions
Appearance
| [unchecked revision] | [checked revision] |
MDElliottMD (talk | contribs) Auto-created stub |
MDElliottMD (talk | contribs) Comprehensive categorization: +Serotonin Antagonist and Reuptake Inhibitors (SARIs) |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{MedTemplate | {{MedTemplate | ||
| generic | | generic = Nefazodone | ||
| brand | | brand = Serzone | ||
| classes | | structure = | ||
| mechanism | | classes = SARI, Antidepressant | ||
| mechanism = Serotonin reuptake inhibitor and 5-HT2A antagonist | |||
| uses = | |||
| starting_dose = | |||
| preparations = | |||
| fda_max = | |||
| routes = | |||
| onset = | |||
| duration = | |||
| halflife = | |||
| bioavailability = | |||
| pregnancy = | |||
| legal = | |||
| intro = | |||
| pharmacokinetics = | |||
| pharmacodynamics = | |||
| indications = | |||
| dosing = | |||
| effects = | |||
| interactions = <pharmaInteractions/> | |||
| pregnancy_details = | |||
| monitoring = | |||
| counseling = | |||
| anecdotes = | |||
| seealso = | |||
| references = | |||
}} | }} | ||
[[Category:Antidepressants]] | [[Category:Antidepressants]] | ||
[[Category:Serotonin Antagonist and Reuptake Inhibitors (SARIs)]] | |||
Latest revision as of 18:42, 15 May 2026
SARI, Antidepressant
Nefazodone
Serzone
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
Fluoxetine via Category:Antidepressants exp n/a/5 outcome n/a (n=1) exp 1.0/5 outcome +33.0 (n=1)
How much experience do you have with this combination (1 a little, 5 a lot)?
How did it go? (-100 worst, +100 best)
- checking this mechanism here
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Pharmacy
Common uses
Classification(s)
Classes
SARI, Antidepressant
Pharmacology
Purported mechanism
Serotonin reuptake inhibitor and 5-HT2A antagonist